-
Mashup Score: 0Exploring adoption rate of 2022 ICC and 2022 WHO Myeloid and Lymphoid Neoplasm Classification in the US - 1 year(s) ago
Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…
Source: redcap.ccf.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
-
“I don’t know who needs to hear this but there is no reason to ever dose iron more than once daily. #hemetwitter #hepcidinwillwin”
Read the original tweet here
Source: TwitterCategories: Hem/Oncs, Latest HeadlinesTweet-
MT @acweyand [Jan 31, 2020] I don’t know who needs to hear this but there is no reason to ever dose iron more than once daily. https://t.co/rN2l8yoOnZ #anemia #hemetwitter #hepcidinwillwin
-
-
Mashup Score: 0Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women - 1 year(s) ago
Key Points. Iron supplements at doses of 60 mg Fe as FeSO4 or higher increase hepcidin for up to 24 hours and are associated with lower iron absorption on the f
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Oral iron increase hepcidin & decrease iron absorption w/ qd or bid doses in iron-depleted young women [10/22/15] Moretti et al. @BloodJournal https://t.co/nonPy7GoxN #anemia #hemetwitter #hepcidinwillwin
-
-
Mashup Score: 0How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia - 1 year(s) ago
Systemic treatment of adult patients with acute lymphoblastic leukemia continues to evolve with the introduction of targeted and T-cell activating therapies, bu
Source: American Society of HematologyCategories: Expert Picks, Latest HeadlinesTweet-
Check out this informative article on prevention and treatment strategies for CNS involvement in acute lymphoblastic leukemia patients. https://t.co/Gyjwm0YE8a @BloodJournal @HemOncFellows #Leusm #CNSdisease #MedTwitter #hemeTwitter
-
-
Mashup Score: 5Exploring adoption rate of 2022 ICC and 2022 WHO Myeloid and Lymphoid Neoplasm Classification in the US - 1 year(s) ago
Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…
Source: redcap.ccf.orgCategories: Hematologists1, Latest HeadlinesTweet-
RT @HadidiSamer: Help us in filling this survey and spreading the word👇 ✅Link: https://t.co/pg7OA2BFXU #leusm #lymsm #mmsm #hemeTwitter #h…
-
-
Mashup Score: 4Exploring adoption rate of 2022 ICC and 2022 WHO Myeloid and Lymphoid Neoplasm Classification in the US - 1 year(s) ago
Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…
Source: redcap.ccf.orgCategories: Latest Headlines, PathologyTweet-
RT @HadidiSamer: Help us in filling this survey and spreading the word👇 ✅Link: https://t.co/pg7OA2BFXU #leusm #lymsm #mmsm #hemeTwitter #h…
-
-
Mashup Score: 2Exploring adoption rate of 2022 ICC and 2022 WHO Myeloid and Lymphoid Neoplasm Classification in the US - 1 year(s) ago
Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…
Source: redcap.ccf.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Help us in filling this survey and spreading the word👇 ✅Link: https://t.co/pg7OA2BFXU #leusm #lymsm #mmsm #hemeTwitter #hemepath @HemOncFellows @AaronGoodman33 @ManniMD1 @amarkelkar @Eddie_Cliff @IMG_Oncologists @OncoAlert @Hemoncq @HemepathUAMS @PathologyUAMS @DavidSteensma https://t.co/mqtnJxg6sJ
-
-
Mashup Score: 0Exploring adoption rate of 2022 ICC and 2022 WHO Myeloid and Lymphoid Neoplasm Classification in the US - 1 year(s) ago
Working… This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again. The value you provided must be within the suggested range The value you provided is outside the suggested range This…
Source: redcap.ccf.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Help us spread the word&complete a survey to understand adoption of ICC/WHO myeloid&lymphoid neoplasm classification in 🇺🇸 ➡️can complete on your phone ✅project led by a fellow (👏) ➡️ https://t.co/pg7OA2BFXU #OncTwitter #HemeTwitter #AcademicTwitter #PathTwitter #hemepath https://t.co/6zFBkctmi0
-
-
Mashup Score: 0Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome - Blood Cancer Journal - 1 year(s) ago
Blood Cancer Journal – Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
A remarkable work regarding HR-MDS from @Ramikomrokji and colleagues. https://t.co/GmQdjDRbGy #HemeTwitter @Nature
-
-
Mashup Score: 0Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding - 1 year(s) ago
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies to coagulation factor VIII that may be secondary to autoimmune diseases, cancer, drugs, pregnancy, infections, or be idiopathic. Recurrent bleeding, often severe, mostly in …
Source: PubMed Central (PMC)Categories: Hem/Oncs, Latest HeadlinesTweet-
This is my personal favorite reference for the management of acquired hemophilia A: https://t.co/KhcEb1mOWK #hemetwitter
-
Only takes few minutes and will help us if you can fill this survey: ➡️ https://t.co/pg7OA2CdNs ➡️We are looking to get everybody opinion #mmsm #hemeTwitter #hemePath #OncTwitter #PathTwitter Please share with colleagues 🙏 the more response we get the better https://t.co/4wvenyMTz5